Survival Benefit in Metastatic CRPC Study Spurs Questions on Patient Selection

(MedPage Today) -- In a recent MedPage Today video, Neeraj Agarwal, MD, of the Huntsman Cancer Institute at the University of Utah in Salt Lake City, reviewed the TALAPRO-2 trial's implications for frontline treatment of metastatic castration-resistant...